Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Return on Capital Employed (2022 - 2025)

Historic Return on Capital Employed for Atara Biotherapeutics (ATRA) over the last 4 years, with Q3 2025 value amounting to 1.69%.

  • Atara Biotherapeutics' Return on Capital Employed fell 33500.0% to 1.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.69%, marking a year-over-year decrease of 33500.0%. This contributed to the annual value of 30.6% for FY2024, which is 284500.0% down from last year.
  • As of Q3 2025, Atara Biotherapeutics' Return on Capital Employed stood at 1.69%, which was down 33500.0% from 0.23% recorded in Q2 2025.
  • Over the past 5 years, Atara Biotherapeutics' Return on Capital Employed peaked at 25.62% during Q2 2024, and registered a low of 7.9% during Q4 2023.
  • Moreover, its 4-year median value for Return on Capital Employed was 0.06% (2025), whereas its average is 3.63%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first soared by 271500bps in 2024, then tumbled by -253900bps in 2025.
  • Over the past 4 years, Atara Biotherapeutics' Return on Capital Employed (Quarter) stood at 0.96% in 2022, then crashed by -727bps to 7.9% in 2023, then surged by 222bps to 9.62% in 2024, then crashed by -82bps to 1.69% in 2025.
  • Its Return on Capital Employed stands at 1.69% for Q3 2025, versus 0.23% for Q2 2025 and 0.36% for Q1 2025.